These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 9678537

  • 1. Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population.
    Mühlberg T, Kirchberger M, Spitzweg C, Herrmann F, Heberling HJ, Heufelder AE.
    Eur J Endocrinol; 1998 Jun; 138(6):686-90. PubMed ID: 9678537
    [Abstract] [Full Text] [Related]

  • 2. Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population.
    Cuddihy RM, Bahn RS.
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4476-8. PubMed ID: 8954062
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease.
    Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ.
    J Clin Lab Anal; 2005 Dec; 19(4):133-8. PubMed ID: 16025481
    [Abstract] [Full Text] [Related]

  • 4. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
    Mühlberg T, Heberling HJ, Joba W, Schworm HD, Heufelder AE.
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
    [Abstract] [Full Text] [Related]

  • 5. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
    Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, Rashidi A, Khosravi F, Amirzargar A.
    Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
    [Abstract] [Full Text] [Related]

  • 6. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
    Mukai T, Hiromatsu Y, Ichimura M, Fukutani T, Kaku H, Miyake I, Shoji S, Koda Y, Bednarczuk T.
    Thyroid; 2006 Mar; 16(3):243-8. PubMed ID: 16571086
    [Abstract] [Full Text] [Related]

  • 7. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene.
    Blakemore AI, Watson PF, Weetman AP, Duff GW.
    J Clin Endocrinol Metab; 1995 Jan; 80(1):111-5. PubMed ID: 7530255
    [Abstract] [Full Text] [Related]

  • 8. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis.
    Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z.
    J Exp Med; 1999 Jun 21; 189(12):1863-74. PubMed ID: 10377182
    [Abstract] [Full Text] [Related]

  • 9. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese.
    Tseng LH, Chen PJ, Lin MT, Shau WY, Chaung SM, Martin PJ, Hansen JA.
    Tissue Antigens; 2001 Apr 21; 57(4):318-24. PubMed ID: 11380940
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-1 receptor antagonist ribonucleic acid and protein expression by cultured Graves' and normal orbital fibroblasts is differentially modulated by dexamethasone and irradiation.
    Mühlberg T, Joba W, Spitzweg C, Schworm HD, Heberling HJ, Heufelder AE.
    J Clin Endocrinol Metab; 2000 Feb 21; 85(2):734-42. PubMed ID: 10690884
    [Abstract] [Full Text] [Related]

  • 11. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis.
    Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L, Melani L, Pizarro TT, Rotter JI, Cominelli F.
    Gastroenterology; 1999 Oct 21; 117(4):806-13. PubMed ID: 10500062
    [Abstract] [Full Text] [Related]

  • 12. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Davies TF.
    Thyroid; 2012 Jul 21; 22(7):730-6. PubMed ID: 22663548
    [Abstract] [Full Text] [Related]

  • 13. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K.
    Clin Endocrinol (Oxf); 2000 Jun 21; 52(6):759-64. PubMed ID: 10848881
    [Abstract] [Full Text] [Related]

  • 14. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q, Yang YM, Lv XY.
    J Zhejiang Univ Sci B; 2006 Nov 21; 7(11):887-91. PubMed ID: 17048303
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
    Vijgen L, Van Gysel M, Rector A, Thoelen I, Esters N, Ceelen T, Vangoidsenhoven E, Vermeire S, Rutgeerts P, Van Ranst M.
    Genes Immun; 2002 Nov 21; 3(7):400-6. PubMed ID: 12424621
    [Abstract] [Full Text] [Related]

  • 16. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD, Bid HK, Ghoshal UC.
    Scand J Gastroenterol; 2005 Jul 21; 40(7):827-31. PubMed ID: 16109659
    [Abstract] [Full Text] [Related]

  • 17. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J, Wang X, Tan G, Wei W, Zhou F, Liang Z, Li H, Yu H.
    J Mol Med (Berl); 2021 Oct 21; 99(10):1487-1495. PubMed ID: 34287665
    [Abstract] [Full Text] [Related]

  • 18. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
    Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD.
    Kidney Int; 2000 Aug 21; 58(2):783-9. PubMed ID: 10916103
    [Abstract] [Full Text] [Related]

  • 19. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.
    Hofbauer LC, Mühlberg T, König A, Heufelder G, Schworm HD, Heufelder AE.
    J Clin Endocrinol Metab; 1997 Jul 21; 82(7):2244-7. PubMed ID: 9215301
    [Abstract] [Full Text] [Related]

  • 20. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF.
    Thyroid; 2008 Nov 21; 18(11):1201-6. PubMed ID: 18925838
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.